R&D spending JW Pharmaceutical South Korea 2014-2023
In 2023, JW Pharmaceutical's R&D spending amounted to approximately 73.6 billion South Korean won. This represents an increase from the previous year. It was also the highest figure recorded since 2014. JW Pharmaceutical's R&D spending to sales ratio has also increased.